SLS logo

SELLAS Life Sciences (SLS)

Profile

Full Name

SELLAS Life Sciences Group, Inc.

Ticker Symbol

SLS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 12, 2008

Indexes

Not included

Website

http://www.sellaslifesciences.com

Employees

15

Key Details

Price

$1.29(+13.16%)

Market cap

$117.19M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.50(+62.69% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.29
SLS price is $1.29

30-Day Relative Volume

1.85
SLS 30-day relative volume is 1.85

Price Performance

Price Most recent change

+13.16%
SLS price was up +13.16% on Apr 15, 2025

Price YTD change

+24.04%
SLS price is up +24.04% since January 1st

Price 1-year change

-3.01%
SLS price is down -3.01% year-on-year

Price 3-year change

-63.35%
SLS price is down -63.35% over the past 3 years

Price Range

Price All-time high

$718500.00
SLS price is currently -100.00% below its historical high of $718500.00

Price 3-year low

$0.50
SLS price is currently +158.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$117.19M
SLS market capitalization is $117.19 million

Market cap 3-year change

+62.12%
SLS market capitalization is up +62.12% over the past 3 years

Market cap All-time high

$807.84M
SLS market capitalization is currently -85.49% below its historical high of $807.84 million

Market cap sector rank

50.25%
SLS market capitalization is higher than 50.25% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+61.45%
SLS shares outstanding is up +61.45% year-on-year

Shares Outstanding 3-Year Change

+342.39%
SLS shares outstanding is up +342.39% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.43
SLS beta is 0.43

200-day SMA

$1.18
SLS price is currently +9.38% above its 200-day simple moving average

50-day SMA

$1.20
SLS price is currently +7.73% above its 50-day simple moving average

RSI

65.01
SLS 14-day relative strength index is 65.01

Volume

1.85
SLS 30-day relative volume is 1.85

ATR

$0.08
SLS average true range is $0.08

10-day Historical Volatility

81.10%
SLS 10-day historical volatility is 81.10%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
SLS annual revenue value is unknown

Revenue Analysts estimate

-
SLS annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
SLS annual revenue 1-year change is unknown

Revenue Sector rank

-
SLS annual revenue is unknown

EPS

EPS

-$0.50
SLS annual earnings per share is -$0.50

EPS Analysts estimate

-$0.42
SLS annual earnings per share is currently +18.12% higher than the consensus analysts' forecast

EPS 1-year change

+62.69%
SLS annual earnings per share is up +62.69% year-on-year

EPS Sector rank

68.93%
SLS annual earnings per share is higher than 68.93% of companies in Healthcare sector

Profit

Gross profit

-
SLS annual gross profit value is unknown

Gross margin

-
SLS annual gross profit margin value is unknown

Operating profit

-$31.51M
SLS annual operating income is -$31.51 million

Operating margin

-
SLS annual operating profit margin value is unknown

Net income

-$30.88M
SLS annual net profit is -$30.88 million

Net margin

-
SLS annual net profit margin value is unknown

Expenses

Total expenses

$31.51M
SLS annual total expenses is $31.51 million

Operating expenses

$31.51M
SLS annual total operating expenses is $31.51 million

Cost of goods sold

-
SLS annual cost of goods sold value is unknown

Selling, general & administrative expenses

$12.42M
SLS annual SGA is $12.42 million

Depreciation and amortization

-
SLS annual depreciation & amortization value is unknown

Interest expense

-
SLS annual interest expense value is unknown

Income tax

-
SLS annual income tax value is unknown

EBIT & EBITDA

EBIT

-$31.51M
SLS annual earnings before interest & taxes is -$31.51 million

EBITDA

-$31.51M
SLS annual EBITDA is -$31.51 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$19.43M
SLS annual total assets is $19.43 million

Non current assets

$3.10M
SLS annual long term assets is $3.10 million

Current assets

$16.33M
SLS annual total current assets is $16.33 million

Cash and cash equivalents

$13.89M
SLS annual cash & cash equivalents is $13.89 million

Accounts receivable

-
SLS annual accounts receivable value is unknown

Inventory

-
SLS annual inventory value is unknown

Liabilities

Total liabilities

$9.97M
SLS annual total liabilities is $9.97 million

Long term liabilities

$457.00K
SLS annual total long term liabilities is $457.00 thousand

Current liabilities

$9.51M
SLS annual total current liabilities is $9.51 million

Accounts payable

$3.50M
SLS annual accounts payable is $3.50 million

Debt

Total debt

$1.00M
SLS annual total debt is $1.00 million

Total debt 1-year change

+10.49%
SLS annual total debt is up +10.49% year-on-year

Long term debt

$457.00K
SLS annual long term debt is $457.00 thousand

Short term debt

$544.00K
SLS annual short term debt is $544.00 thousand

Equity & Capital

Shareholders equity

$9.46M
SLS annual stockholders equity is $9.46 million

Book value

$9.46M
SLS annual book value is $9.46 million

Retained earnings

-$248.13M
SLS annual retained earnings is -$248.13 million

Working capital

$6.82M
SLS annual working capital is $6.82 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$35.40M
SLS annual cash flow from operations is -$35.40 million

Cash from operations 1-year change

-12.71%
SLS annual cash flow from operations is down -12.71% year-on-year

Cash from investing

$0.00
SLS annual cash flow from investing activities is $0.00

Cash from investing 1-year change

+100%
SLS annual cash flow from investing activities is up +100% year-on-year

Cash from financing

$46.76M
SLS annual cash flow from financing activities is $46.76 million

Cash from financing 1-year change

+109.54%
SLS annual cash flow from financing activities is up +109.54% year-on-year

CAPEX

CAPEX

-
SLS annual capital expenditures value is unknown

CAPEX 1-year change

-
SLS annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$35.40M
SLS annual free cash flow is -$35.40 million

Free cash flow 1-year change

+4.09%
SLS annual free cash flow is up +4.09% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
SLS annual gross profit margin value is unknown

Operating margin

-
SLS annual operating profit margin value is unknown

Net margin

-
SLS annual net profit margin value is unknown

ROA & ROE

ROA

-158.92%
SLS annual return on assets is -158.92%

ROE

-326.27%
SLS annual return on equity is -326.27%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SLS price to earnings ratio value is unknown

PE ratio Sector rank

-
SLS price to earnings ratio is unknown

PB Ratio

PB ratio

12.38
SLS price to book ratio is 12.38

PB ratio Sector rank

94.4%
SLS price to book ratio is higher than 94.4% of companies in Healthcare sector

PS Ratio

PS ratio

-
SLS price to sales ratio value is unknown

PS ratio Sector rank

-
SLS price to sales ratio is unknown

Enterprise value

Enterprise value

$104.31M
SLS enterprise value is $104.31 million

Enterprise value Sector rank

50.7%
SLS enterprise value is higher than 50.7% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.31
SLS EV/EBITDA is -3.31

EV/EBITDA Sector rank

24.54%
SLS EV/EBITDA is higher than 24.54% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.72
SLS annual current ratio is 1.72

Quick ratio

-
SLS annual quick ratio value is unknown

Leverage

Debt to equity

0.11
SLS annual debt to equity ratio is 0.11

Interest coverage ratio

-
SLS annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
SLS piotroski f-score value is unknown

Altman Z-Score

-
SLS altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Nov 22, 23 Cantor Fitzgerald
Overweight
Sep 7, 23 Cantor Fitzgerald
Overweight
Nov 15, 22 Alliance Global Partners
Buy
Jun 28, 22 Cantor Fitzgerald
Overweight
Jul 21, 21 Cantor Fitzgerald
Overweight
Nov 18, 19 Oppenheimer
Outperform
Nov 18, 19 Maxim Group
Buy
Nov 18, 19 H.C. Wainwright
Buy
Nov 18, 19 Alliance Global Partners
Buy
Nov 15, 19 Maxim Group
Buy

Institutional Ownership

Similar stocks

GLSI logo
Greenwich LifeSciences (GLSI)
IRWD logo
Ironwood Pharmaceuticals (IRWD)
BioAge Labs (BIOA)
NKTR logo
Nektar Therapeutics (NKTR)
ADCT logo
ADC Therapeutics SA (ADCT)
Eupraxia Pharmaceuticals (EPRX)
LRMR logo
Larimar Therapeutics (LRMR)
Kalaris Therapeutics (KLRS)
ACRS logo
Aclaris Therapeutics (ACRS)
  • What is the ticker symbol for SELLAS Life Sciences?
  • Does SELLAS Life Sciences pay dividends?
  • What sector is SELLAS Life Sciences in?
  • What industry is SELLAS Life Sciences in?
  • What country is SELLAS Life Sciences based in?
  • When did SELLAS Life Sciences go public?
  • Is SELLAS Life Sciences in the S&P 500?
  • Is SELLAS Life Sciences in the NASDAQ 100?
  • Is SELLAS Life Sciences in the Dow Jones?
  • When was SELLAS Life Sciences's last earnings report?
  • When does SELLAS Life Sciences report earnings?
  • Should I buy SELLAS Life Sciences stock now?

What is the ticker symbol for SELLAS Life Sciences?

The ticker symbol for SELLAS Life Sciences is NASDAQ:SLS

Does SELLAS Life Sciences pay dividends?

No, SELLAS Life Sciences does not pay dividends

What sector is SELLAS Life Sciences in?

SELLAS Life Sciences is in the Healthcare sector

What industry is SELLAS Life Sciences in?

SELLAS Life Sciences is in the Biotechnology industry

What country is SELLAS Life Sciences based in?

SELLAS Life Sciences is headquartered in United States

When did SELLAS Life Sciences go public?

SELLAS Life Sciences's initial public offering (IPO) was on March 12, 2008

Is SELLAS Life Sciences in the S&P 500?

No, SELLAS Life Sciences is not included in the S&P 500 index

Is SELLAS Life Sciences in the NASDAQ 100?

No, SELLAS Life Sciences is not included in the NASDAQ 100 index

Is SELLAS Life Sciences in the Dow Jones?

No, SELLAS Life Sciences is not included in the Dow Jones index

When was SELLAS Life Sciences's last earnings report?

SELLAS Life Sciences's most recent earnings report was on Nov 13, 2024

When does SELLAS Life Sciences report earnings?

The next expected earnings date for SELLAS Life Sciences is May 14, 2025

Should I buy SELLAS Life Sciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page